Literature DB >> 14733841

Treatment of adrenocortical carcinoma: contemporary outcomes.

David Y T Chen1, R Ernest Sosa, Douglas S Scherr.   

Abstract

Adrenocortical carcinoma is a rare cancer that historically has been associated with poor outcome. Throughout the past decades, growing experience has allowed better understanding of the natural history and optimal management of this cancer. Advances in imaging and aggressive surgical therapy have raised the outlook for recently diagnosed patients. Further improvements in survival will require more effective systemic therapy.

Entities:  

Mesh:

Year:  2004        PMID: 14733841     DOI: 10.1007/s11934-004-0014-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  48 in total

1.  Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases.

Authors:  D A MACFARLANE
Journal:  Ann R Coll Surg Engl       Date:  1958-09       Impact factor: 1.891

2.  Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients.

Authors:  A A Kasperlik-Zeluska; E Rosłonowska; J Słowinska-Srzednicka; B Migdalska; W Jeske; A Makowska; H Snochowska
Journal:  Clin Endocrinol (Oxf)       Date:  1997-01       Impact factor: 3.478

3.  Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? results of surgical treatment in 31 patients.

Authors:  G Favia; F Lumachi; D F D'Amico
Journal:  World J Surg       Date:  2001-06       Impact factor: 3.352

4.  Is MRI more accurate than CT in estimating the real size of adrenal tumours?

Authors:  C Kouriefs; K Mokbel; C Choy
Journal:  Eur J Surg Oncol       Date:  2001-08       Impact factor: 4.424

5.  Limitations of size as a criterion in the evaluation of adrenal tumors.

Authors:  C C Barnett; D G Varma; A K El-Naggar; A P Dackiw; G A Porter; A S Pearson; A P Kudelka; R F Gagel; D B Evans; J E Lee
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

6.  Adrenocortical carcinoma: surgical progress or status quo?

Authors:  M L Kendrick; R Lloyd; L Erickson; D R Farley; C S Grant; G B Thompson; C Rowland; W F Young; J A van Heerden
Journal:  Arch Surg       Date:  2001-05

7.  Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases.

Authors:  D R King; E E Lack
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

8.  A clinical and pathological study of adrenocortical carcinoma: therapeutic implications.

Authors:  T F Hogan; K W Gilchrist; D W Westring; D L Citrin
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

9.  Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms.

Authors:  Electron Kebebew; Allan E Siperstein; Orlo H Clark; Quan-Yang Duh
Journal:  Arch Surg       Date:  2002-08

10.  Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.

Authors:  M D Wooten; D K King
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

View more
  4 in total

1.  Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?

Authors:  Electron Kebebew; Emily Reiff; Quan-Yang Duh; Orlo H Clark; Alex McMillan
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Estrogen receptor expression in adrenocortical carcinoma.

Authors:  Xiao-cao Shen; Cai-xiao Gu; Yi-qing Qiu; Chuan-jun Du; Yan-biao Fu; Jian-jun Wu
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

3.  The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study.

Authors:  Eliza Sharma; Suyash Dahal; Pratibha Sharma; Abani Bhandari; Vishal Gupta; Birendra Amgai; Sumit Dahal
Journal:  J Clin Med Res       Date:  2018-06-27

4.  What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.

Authors:  Denise Garcia; Julie B Siegel; David A Mahvi; Biqi Zhang; David M Mahvi; E Ramsay Camp; Whitney Graybill; Stephen J Savage; Antonio Giordano; Sara Giordano; Denise Carneiro-Pla; Mahsa Javid; Aaron P Lesher; Andrea Abbott; Nancy Klauber DeMore
Journal:  Clin Oncol Res       Date:  2020-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.